Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kanto Denka Kogyo Co., Ltd. (4047.T)
Tokyo, JP
Kanto Denka Kogyo Co., Ltd., founded in Tokyo, Japan, in 1938, is an international manufacturer and supplier of a diverse range of chemical products, segmented into two main divisions: Fundamental Chemicals and Fine Chemicals. The Fundamental Chemicals division produces inorganic compounds like caustic soda, hydrochloric acid, sodium hypochlorite, and aluminum chloride, which are essential for pulp and paper production, soap and detergent manufacturing, various chemical syntheses, aluminum electrolytic capacitors, and as intermediates for pharmaceuticals and agricultural products. These chemicals also play key roles in water treatment, metal surface preparation, as food additives, sterilizers, bleaching agents, oxidizers, and catalysts for reactions such as Friedel-Crafts. This division also provides organic compounds, including trichloroethylene, perchloroethylene, vinylidene chloride, and cyclohexanol. These are utilized in cleaning metal parts, the synthesis of hydrofluorocarbons, the creation of pharmaceutical and agricultural intermediates, the production of fire-resistant fibers and resins for food packaging, as organic solvents, and in processes like oil refining catalyst regeneration and dry cleaning. The Fine Chemicals division specializes in advanced chemical products. Its ferrochemicals, such as reprographics carriers and magnetite, are crucial for printers, reprographic systems, and environmentally friendly carrier solutions. Additionally, this division manufactures an extensive array of fluorochemicals, encompassing compounds like sulfur hexafluoride, carbon tetrafluoride, trifluoromethane, hexafluoroethane, nitrogen trifluoride, octafluoropropane, tungsten hexafluoride, silicon tetrafluoride, chlorine trifluoride, octafluorocyclobutane, hexafluoro-1,3-butadiene, iodine pentafluoride, and lithium hexafluorophosphate. These high-performance substances are vital for industries involved in semiconductors, liquid crystals and their displays, modern rechargeable batteries, optical fibers, and high-capacity transformers. Kanto Denka Kogyo further supplies lithium tetrafluoroborate and hexafluorophosphate, which are critical components for electrolytes and additives in lithium-ion rechargeable batteries.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +7.95% | +25.61% | +19.81% | +102.97% | +80.30% | +138.93% | +134.02% | +128.29% | +126.77% | +482.39% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+4.9% ★ Q1'26: +18.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+16.7% ★ Q1'26: +49.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-3.0% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+8.4% Q1'26: +15.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+3.9% Q1'26: +8.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.1% ★ Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×2.69× Q1'26: 1.81× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
38.36B
est: 37.80B (+1.5%)
|
43.01B
est: 43.40B (-0.9%)
|
46.04B
est: 46.00B (+0.1%)
|
51.31B
est: 52.00B (-1.3%)
|
55.20B
est: 55.00B (+0.4%)
|
53.68B
est: 53.75B (-0.1%)
|
51.93B
est: 51.07B (+1.7%)
|
62.29B
est: 62.00B (+0.5%)
|
78.68B
est: 80.00B (-1.7%)
|
64.77B
est: 63.91B (+1.3%)
|
62.35B
est: 63.25B (-1.4%)
|
67.00B
66.85B – 67.15B
+5.9% YoY
|
75.90B
73.00B – 78.80B
+13.3% YoY
|
86.80B
85.25B – 88.35B
+14.4% YoY
|
| EBITDA |
7.18B
est: 8.12B (-11.6%)
|
11.11B
est: 9.32B (+19.1%)
|
12.24B
est: 9.88B (+23.8%)
|
13.43B
est: 11.17B (+20.2%)
|
14.50B
est: 11.82B (+22.7%)
|
13.20B
est: 11.55B (+14.3%)
|
12.44B
est: 10.97B (+13.3%)
|
17.85B
est: 13.32B (+34.0%)
|
20.65B
est: 17.19B (+20.1%)
|
6.53B
est: 13.76B (-52.6%)
|
12.52B
est: 13.62B (-8.1%)
|
14.43B
14.39B – 14.46B
+5.9% YoY
|
16.34B
15.72B – 16.97B
+13.3% YoY
|
18.69B
18.36B – 19.02B
+14.4% YoY
|
| EBIT |
4.63B
est: 3.59B (+28.7%)
|
8.65B
est: 4.13B (+109.6%)
|
9.36B
est: 4.37B (+114.1%)
|
9.05B
est: 4.94B (+83.0%)
|
9.45B
est: 5.23B (+80.7%)
|
7.73B
est: 5.11B (+51.3%)
|
5.67B
est: 4.86B (+16.8%)
|
11.17B
est: 5.90B (+89.4%)
|
12.95B
est: 7.61B (+70.2%)
|
-1.97B
est: 5.95B (-133.1%)
|
4.27B
est: 5.89B (-27.5%)
|
6.24B
6.23B – 6.26B
+5.9% YoY
|
7.07B
6.80B – 7.34B
+13.3% YoY
|
8.09B
7.94B – 8.23B
+14.4% YoY
|
| Net Income |
4.53B
est: 3.80B (+19.4%)
|
8.07B
est: 6.34B (+27.3%)
|
6.69B
est: 5.84B (+14.4%)
|
6.12B
est: 6.19B (-1.3%)
|
6.55B
est: 6.69B (-2.1%)
|
5.02B
est: 5.29B (-5.1%)
|
3.61B
est: 3.05B (+18.3%)
|
7.76B
est: 7.48B (+3.8%)
|
9.38B
est: 9.40B (-0.2%)
|
-4.61B
est: -3.14B (-47.0%)
|
3.25B
est: 2.96B (+9.7%)
|
2.95B
2.81B – 3.10B
-0.3% YoY
|
5.00B
4.43B – 5.98B
+69.3% YoY
|
7.11B
6.94B – 7.27B
+42.1% YoY
|
| SGA |
4.79B
est: 4.72B (+1.5%)
|
5.21B
est: 5.42B (-3.8%)
|
5.40B
est: 5.74B (-5.9%)
|
5.86B
est: 6.49B (-9.7%)
|
6.21B
est: 6.86B (-9.5%)
|
6.68B
est: 6.71B (-0.3%)
|
6.47B
est: 6.37B (+1.5%)
|
7.21B
est: 7.74B (-6.8%)
|
8.47B
est: 9.98B (-15.1%)
|
7.77B
est: 8.03B (-3.3%)
|
7.90B
est: 7.95B (-0.6%)
|
8.42B
8.40B – 8.44B
+5.9% YoY
|
9.54B
9.18B – 9.90B
+13.3% YoY
|
10.91B
10.72B – 11.10B
+14.4% YoY
|
| EPS |
78.81
est: 66.10 (+19.2%)
|
140.25
est: 110.27 (+27.2%)
|
116.23
est: 101.70 (+14.3%)
|
106.32
est: 107.80 (-1.4%)
|
113.90
est: 116.50 (-2.2%)
|
87.29
est: 92.10 (-5.2%)
|
62.72
est: 53.03 (+18.3%)
|
135.11
est: 130.15 (+3.8%)
|
163.30
est: 163.65 (-0.2%)
|
-80.24
est: -54.57 (-47.1%)
|
56.53
est: 51.60 (+9.6%)
|
51.45
48.92 – 53.98
-0.3% YoY
|
90.70
77.27 – 104.13
+76.3% YoY
|
123.80
120.93 – 126.67
+36.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-14 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-13 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-12 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 4/5 |
| 2026-05-01 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares International Developed Small Cap Value Factor ETF ISVL | 0.15% | 473.1K | 0.31% |
| 2 | Avantis International Small Cap Value ETF AVDV | 0.13% | 24.22M | 0.36% |
| 3 | WisdomTree Japan SmallCap Dividend Fund DFJ | 0.08% | 300.0K | 0.58% |
| 4 | Dimensional - International Small Cap ETF DFIS | 0.06% | 3.22M | 0.39% |
| 5 | State Street SPDR S&P International Small Cap ETF GWX | 0.05% | 456.7K | 0.40% |
| 6 | Avantis International Small Cap Equity ETF AVDS | 0.05% | 145.6K | 0.30% |
| 7 | WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc DXJD.SW | 0.04% | 414.6K | 0.45% |
| 8 | WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc DXJF.MI | 0.04% | 382.6K | 0.45% |
| 9 | WisdomTree Japan Equity UCITS ETF DXJ.L | 0.04% | 335.8K | 0.48% |
| 10 | WisdomTree Japan Equity UCITS ETF - GBP Hedged DXJP.L | 0.04% | 449.2K | 0.45% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akira Muranushi | Senior Executive Officer | — | — |
| Go Takikawa | Managing Executive Officer | — | male |
| Hiromi Oya | Senior Executive Officer | — | — |
| Jun'ichi Hasegawa | Chief Executive Officer, President & Representative Director | — | male |
| Kazuki Niimi | Managing Executive Officer, Head of Accounting, Finance & Information Systems Dept & Director | — | male |
| Kenichi Yako | Executive Officer, Head of Technology Division & Director | — | male |
| Masatomo Hayashi | Managing Executive Officer & Director | — | — |
| Taisuke Yonemura | Executive Officer & Director | — | — |
| Yuki Abe | Managing Executive Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4047.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
